Table 2.
Effect of monotherapies and dual therapies on neuronal injury assessed by fluoro-jade B staining.
| SE control (n= 5) | Valp 270 mg/kg (n=5) | Mz 9mg/kg (n=10) | Ket 90 mg/kg (n=7) | Mz 4.5 + Ket 45 (n= 9) | |
|---|---|---|---|---|---|
| Frontoparietal cortex | 4 (1-4) | 4 (4) | 2 (1-4) | 1 (1) *•• | 1 (1-2) *•• |
| Entorhinal cortex | 4 (4) | 4 (4) | 1 (1-4) | 1 (1) **•• | 1 (1) **•• |
| Piriform cortex | 4 (4) | 4 (4) | 1 (1-4) | 1 (1) **•• | 1 (1-2) **•• |
| Thalamus | 4 (1-4) | 4 (3-4) | 2 (1-4) | 1 (1-2) • | 1 (1) *•• |
| Amygdala | 4 (4) | 4 (4) | 2 (1-4) | 1 (1-2) *• | 1 (1) **•• |
The first numbers represent the median damage score. The numbers in parentheses indicate the range of neuronal injury.
p < 0.05 or
p <0.01 vs SE control
p <0.05 or
p <0.01 vs valproate.